Lawsuit Overview
August 22, 2022 - An investor in shares of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) filed a lawsuit in the U.S. District Court for the District of Colorado over alleged violations of Federal Securities Laws by Ampio Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between December 29, 2020 and August 3, 2022. Englewood, CO based ...
You must register (for free) or login to view the entire case.